Latest Hematology & Oncology News
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Adding Ipilimumab to Nivolumab No Better in Pretreated Squamous NSCLC
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Ruxolitinib Best for Glucocorticoid-Refractory, -Dependent GVHD
posted July 15th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy 
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis 
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 
Exercise Intervention Linked to Improved Attention, Memory in Breast Cancer Hematology & Oncology Conference Highlights
Hematology & Oncology Monthly Briefings
Hematology & Oncology Conference News
Stay Connected
